Centessa Pharmaceuticals Limited CNTA · Stock Open Centessa Pharmaceuticals Limited in new tab
Centessa Pharmaceuticals Limited Analysis (CNTA)
Is Centessa Pharmaceuticals Limited a good investment? Centessa Pharmaceuticals Limited (CNTA) is currently trading at 40.50 USD. Market analysts have a consensus price target of 44.57 USD. This suggests a potential upside from current levels.
Earnings Schedule: Centessa Pharmaceuticals Limited is expected to release its next earnings report on Aug. 11, 2026. The market consensus estimate for Forward EPS is -1.90.
For income investors, Centessa Pharmaceuticals Limited pays a dividend yield of 93.83%.
Investor FAQ
Does Centessa Pharmaceuticals Limited pay a dividend?
Yes, it pays an annual dividend of 38.00 USD (93.83% yield).
What asset class is Centessa Pharmaceuticals Limited?
Centessa Pharmaceuticals Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 11, 2026. The company currently has a trailing EPS of -1.46.
Company Profile
Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
| Year | Total Dividends |
|---|---|
| ▸2026 |
38.00 USD
|
| June 24, 2026 | 38.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Centessa Pharmaceuticals Limited | Jun 24, 2026 | Paid | 38.0 USD |
Community Discussion